ArticleCancers2024

Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer.

Faithlore P Gardner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.